Last reviewed · How we verify
NCT04391816
COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
trial in Alcohol Drinking in 1,500 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 3 June 2020 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Conditions studied
- Alcohol Drinking — all drugs for Alcohol Drinking →
- Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
- Pandemic — all drugs for Pandemic →
- Psychological Stress — all drugs for Psychological Stress →
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Who can join
Adults 18 to 100, any sex, with Alcohol Drinking or Alcohol-Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The SARS-CoV-2 virus has caused a pandemic infection called COVID-19. It is a global threat to people, communities, and health systems. Researchers are concerned about the mental health effects of the pandemic. They want to learn more about how it is affecting people s alcohol use and problems, and how it may continue to affect them over time. Objective: To study the impact of the COVID-19 pandemic on alcohol use and consequences in individuals across the spectrum of alcohol use and those with alcohol use disorder. Eligibility: Participants who have been screened under the NIAAA Screening, Assessment and Management Protocol (14-AA-0181) Design: Participants will complete a baseline survey by phone. It will ask about alcohol use, alcohol dependence, and stress. It covers 2 time periods: the 12 months before the pandemic started and the time since it started. Participants will get an ID code and a link to an online survey. They will complete the online survey within a week of the phone survey. Participants will complete a series of online surveys over 24 months. For the first year, surveys will be completed weekly for the first 4 weeks, then biweekly for the next 8 weeks, and then every 1-2 months for the rest of the year. For the second year, surveys will be completed every 6 months. Surveys will cover the following topics: * Alcohol use and its consequences * Other substance use * Stress * Impact of the COVID-19 pandemic * Pain * Physical health * Sleep * Quality of life. Because the course of the pandemic may change, the frequency of the surveys may change. Participation lasts 2 years.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
A person-centered approach to capture health disparities and multidimensional impact of COVID-related stressors.
Luk JW, Stangl BL, Schwandt ML, Gunawan T, et al · · 2023 · cited 24× · PMID 36006708 · DOI 10.1037/amp0001044 -
Changes in Alcohol-Related Behaviors and Quality of Life During the COVID-19 Pandemic: Impact of Alcohol Use Disorder Diagnosis and Treatment History.
Luk JW, Stangl BL, Gunawan T, Schwandt ML, et al · · 2022 · cited 12× · PMID 36350598 · DOI 10.4088/jcp.22br14462 -
Chemosensory Alterations and Impact on Quality of Life in Persistent Alcohol Drinkers.
Agarwal K, Luk JW, Manza P, McDuffie C, et al · · 2023 · cited 10× · PMID 36208183 · DOI 10.1093/alcalc/agac047 -
Associations of history of alcohol use disorder with loneliness, social support, and mental health during the COVID-19 pandemic.
Luk JW, Leiter N, Stangl BL, Gunawan T, et al · · 2024 · cited 9× · PMID 38479194 · DOI 10.1016/j.psychres.2024.115826 -
Exercising healthy behaviors: A latent class analysis of positive coping during the COVID-19 pandemic and associations with alcohol-related and mental health outcomes.
McCabe EM, Luk JW, Stangl BL, Schwandt ML, et al · · 2024 · cited 5× · PMID 38354113 · DOI 10.1371/journal.pone.0297060 -
Drinking motives link positive and negative life events to problematic alcohol use during the COVID-19 pandemic: a longitudinal study.
Geda DW, Stangl BL, Arsenault A, Thompson MF, et al · · 2024 · cited 3× · PMID 39367531 · DOI 10.1093/alcalc/agae068 -
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms.
Agarwal K, Luk JW, Stangl BL, Schwandt ML, et al · · 2024 · cited 3× · PMID 38776446 · DOI 10.1097/adm.0000000000001332 -
Treatment access gap during the COVID-19 Pandemic: impact on problematic alcohol use and the moderating roles of perceived stress and resilience.
Vergeer RR, Luk JW, Stangl BL, McCabe EM, et al · · 2024 · cited 2× · PMID 39735429 · DOI 10.3389/fpsyt.2024.1487277
Verify or expand the search:
- PubMed search for NCT04391816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
Other National Institute on Alcohol Abuse and Alcoholism (NIAAA) trials
Trials by the same sponsor.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT06819189 — Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors · Phase 1 · recruiting
- NCT06269627 — Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder · Phase 4 · recruiting
- NCT06484075 — Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04391816 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04391816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing